Browse Category

NASDAQ:APH News 22 October 2025 - 25 January 2026

Amphenol stock slips as Wall Street waits for earnings next week

Amphenol stock slips as Wall Street waits for earnings next week

Amphenol shares fell about 0.9% to $151.14 Friday afternoon as investors awaited its quarterly report due January 28. Trading volume was below average, with focus on the integration of the recently acquired CommScope connectivity business. The company expects the deal to boost adjusted profits by 2026. Broader U.S. markets were mixed, with the Dow down and S&P 500 near flat.
Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol’s stock (NYSE: APH) has erupted this October amid record results and AI-driven demand. The connectors-and-sensors maker is capitalizing on the tech boom. Record-Breaking Q3 Results and Guidance Amphenol’s Q3 2025 results (announced Oct 22) were truly outstanding. Sales hit $6.2 billion – up 53% from a year ago – and adjusted EPS was $0.93 (+86% YoY) businesswire.com, far above analysts’ $0.79 estimate. CEO R. Adam Norwitt said they “closed Q3 with record sales and Adjusted EPS, both significantly exceeding the high end of our guidance” businesswire.com. Operating margin hit a record 27.5% and cash flow was robust ($1.5B). In short, the

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop